• Botanix Pharmaceuticals requests trading halt pending announcement on potential capital raising
• Trading halt to remain in place until earlier of announcement release or market open on 17 February 2026
• Company not aware of any reason why trading halt should not be granted

Botanix Pharmaceuticals Ltd (ASX: BOT) has requested a trading halt of its securities pending the release of an announcement regarding a potential capital raising. The company has requested the trading halt pursuant to Listing Rule 17.1, stating that the trading halt is requested pending the release of an announcement by the company about the potential capital raising. The trading halt will remain in place until the earlier of the release of the announcement regarding the potential capital raising, and the commencement of normal trading on Tuesday, 17 February 2026. Botanix Pharmaceuticals has confirmed that it is not aware of any reason why the trading halt should not be granted, and that it is not aware of any other information necessary to inform the market about the trading halt.